Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Dec;76(Suppl 5):v53–v59. doi: 10.1136/jnnp.2005.082537

Treatment of dementia

R Overshott, A Burns
PMCID: PMC1765710  PMID: 16291922

Full Text

The Full Text of this article is available as a PDF (86.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auriacombe S., Pere J. J., Loria-Kanza Y., Vellas B. Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil. Curr Med Res Opin. 2002;18(3):129–138. doi: 10.1185/030079902125000471. [DOI] [PubMed] [Google Scholar]
  2. Ballard Clive, Cream Julia. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument. Int Psychogeriatr. 2005 Mar;17(1):4–29. doi: 10.1017/s1041610205221026. [DOI] [PubMed] [Google Scholar]
  3. Cohen-Mansfield Jiska. Nonpharmacologic interventions for psychotic symptoms in dementia. J Geriatr Psychiatry Neurol. 2003 Dec;16(4):219–224. doi: 10.1177/0891988703258665. [DOI] [PubMed] [Google Scholar]
  4. De Deyn Peter Paul, Katz Ira R., Brodaty Henry, Lyons Benjamin, Greenspan Andrew, Burns Alistair. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clin Neurol Neurosurg. 2005 Oct;107(6):497–508. doi: 10.1016/j.clineuro.2005.03.013. [DOI] [PubMed] [Google Scholar]
  5. Emre Murat, Aarsland Dag, Albanese Alberto, Byrne E. Jane, Deuschl Günther, De Deyn Peter P., Durif Franck, Kulisevsky Jaime, van Laar Teus, Lees Andrew. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med. 2004 Dec 9;351(24):2509–2518. doi: 10.1056/NEJMoa041470. [DOI] [PubMed] [Google Scholar]
  6. Erkinjuntti Timo, Román Gustavo, Gauthier Serge, Feldman Howard, Rockwood Kenneth. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke. 2004 Mar 4;35(4):1010–1017. doi: 10.1161/01.STR.0000120731.88236.33. [DOI] [PubMed] [Google Scholar]
  7. Evans John Grimley, Wilcock Gordon, Birks Jacqueline. Evidence-based pharmacotherapy of Alzheimer's disease. Int J Neuropsychopharmacol. 2004 Jul 1;7(3):351–369. doi: 10.1017/S1461145704004444. [DOI] [PubMed] [Google Scholar]
  8. Herrmann Nathan, Mamdani Muhammad, Lanctôt Krista L. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry. 2004 Jun;161(6):1113–1115. doi: 10.1176/appi.ajp.161.6.1113. [DOI] [PubMed] [Google Scholar]
  9. Kaduszkiewicz Hanna, Zimmermann Thomas, Beck-Bornholdt Hans-Peter, van den Bussche Hendrik. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ. 2005 Aug 6;331(7512):321–327. doi: 10.1136/bmj.331.7512.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kurz A., Van Baelen B. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration. Dement Geriatr Cogn Disord. 2004 Jun 28;18(2):217–226. doi: 10.1159/000079388. [DOI] [PubMed] [Google Scholar]
  11. McKeith I., Del Ser T., Spano P., Emre M., Wesnes K., Anand R., Cicin-Sain A., Ferrara R., Spiegel R. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 2000 Dec 16;356(9247):2031–2036. doi: 10.1016/S0140-6736(00)03399-7. [DOI] [PubMed] [Google Scholar]
  12. Overshott Ross, Byrne Jane, Burns Alistair. Nonpharmacological and pharmacological interventions for symptoms in Alzheimer's disease. Expert Rev Neurother. 2004 Sep;4(5):809–821. doi: 10.1586/14737175.4.5.809. [DOI] [PubMed] [Google Scholar]
  13. Potyk Darryl. Treatments for Alzheimer disease. South Med J. 2005 Jun;98(6):628–635. doi: 10.1097/01.SMJ.0000166671.86815.C1. [DOI] [PubMed] [Google Scholar]
  14. Rosen W. G., Mohs R. C., Davis K. L. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984 Nov;141(11):1356–1364. doi: 10.1176/ajp.141.11.1356. [DOI] [PubMed] [Google Scholar]
  15. Sano M., Ernesto C., Thomas R. G., Klauber M. R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C. W., Pfeiffer E. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997 Apr 24;336(17):1216–1222. doi: 10.1056/NEJM199704243361704. [DOI] [PubMed] [Google Scholar]
  16. Sano Mary, Wilcock Gordon K., van Baelen Bart, Kavanagh Shane. The effects of galantamine treatment on caregiver time in Alzheimer's disease. Int J Geriatr Psychiatry. 2003 Oct;18(10):942–950. doi: 10.1002/gps.1000. [DOI] [PubMed] [Google Scholar]
  17. Schneider L. S., Olin J. T., Doody R. S., Clark C. M., Morris J. C., Reisberg B., Schmitt F. A., Grundman M., Thomas R. G., Ferris S. H. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11 (Suppl 2):S22–S32. doi: 10.1097/00002093-199700112-00004. [DOI] [PubMed] [Google Scholar]
  18. Stern R. G., Mohs R. C., Davidson M., Schmeidler J., Silverman J., Kramer-Ginsberg E., Searcey T., Bierer L., Davis K. L. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry. 1994 Mar;151(3):390–396. doi: 10.1176/ajp.151.3.390. [DOI] [PubMed] [Google Scholar]
  19. Tariot Pierre N., Farlow Martin R., Grossberg George T., Graham Stephen M., McDonald Scott, Gergel Ivan, Memantine Study Group Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA. 2004 Jan 21;291(3):317–324. doi: 10.1001/jama.291.3.317. [DOI] [PubMed] [Google Scholar]
  20. Wilcock G. K., Birks J., Whitehead A., Evans Sir John Grimley. The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials. Int J Geriatr Psychiatry. 2002 Feb;17(2):175–183. doi: 10.1002/gps.545. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES